Recombinant Human CDH23 Protein，His

CDH23 (Cadherin 23) is a member of the cadherin superfamily, which plays a critical role in cell adhesion processes and has been extensively studied due to its association with auditory function and hereditary deafness. Mutations in the CDH23 gene are linked to a range of auditory phenotypes, particularly nonsyndromic hearing loss, highlighting its importance in the integrity of the hair cells in the inner ear. The protein is predominantly expressed in sensory cells of the inner ear, where it participates in the formation of the hair cell tip links, essential for mechanoelectrical transduction. Furthermore, CDH23 is implicated in maintaining cell-cell junctions and contributes to the structural organization required for proper auditory signal transduction. Research on recombinant CDH23 protein has gained momentum to investigate its structural and functional dynamics, providing insights into its role in cell adhesion and the molecular mechanisms underlying hearing loss. By generating and analyzing recombinant CDH23, researchers aim to understand its binding properties, interactions with other proteins, and the implications of specific mutations on its function. This knowledge is not only vital for elucidating the pathophysiology of auditory disorders but also holds potential for the development of targeted therapies and diagnostic tools for hearing impairment. The study of CDH23 and its recombinant form represents a crucial intersection of molecular biology, genetics, and audiology, paving the way for advancements in understanding and potentially treating auditory-related conditions.